Compound Rh2 (Anticancer agent 133) is a cytotoxic small molecule that inhibits metastasis by suppressing EGFR via FAK/integrin beta1 signaling. It induces cell cycle arrest, apoptosis, and autophagy, demonstrating activity in both in vitro and in vivo cancer research models.
Molecular Weight:
602.71
Formula:
C24H19Cl3N5ORh
Target:
Apoptosis,Autophagy,EGFR
* VAT and and shipping costs not included. Errors and price changes excepted
